12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Inhaled nitric oxide regulatory update

GeNO said FDA accepted for review an NDA for inhaled NO delivered via the GeNOsyl MVG-2000 Nitric Oxide Delivery System to treat neonates with hypoxic respiratory failure. GeNO said the PDUFA date is in June 2013, but the...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >